- Home
- OTLK vs FURY Comparison
OTLK vs FURY Comparison
Compare OTLK & FURY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- FURY
- Stock Information
- Founded
- OTLK 2010
- FURY 2008
- Country
- OTLK United States
- FURY Canada
- Employees
- OTLK N/A
- FURY N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- FURY Precious Metals
- Sector
- OTLK Health Care
- FURY Basic Materials
- Exchange
- OTLK Nasdaq
- FURY Nasdaq
- Market Cap
- OTLK 64.6M
- FURY 55.7M
- IPO Year
- OTLK 2016
- FURY N/A
- Fundamental
- Price
- OTLK $1.83
- FURY $0.40
- Analyst Decision
- OTLK Strong Buy
- FURY Strong Buy
- Analyst Count
- OTLK 5
- FURY 1
- Target Price
- OTLK $21.00
- FURY $1.10
- AVG Volume (30 Days)
- OTLK 892.5K
- FURY 133.2K
- Earning Date
- OTLK 02-12-2025
- FURY 11-12-2024
- Dividend Yield
- OTLK N/A
- FURY N/A
- EPS Growth
- OTLK N/A
- FURY N/A
- EPS
- OTLK N/A
- FURY N/A
- Revenue
- OTLK N/A
- FURY N/A
- Revenue This Year
- OTLK N/A
- FURY N/A
- Revenue Next Year
- OTLK $396.84
- FURY N/A
- P/E Ratio
- OTLK N/A
- FURY N/A
- Revenue Growth
- OTLK N/A
- FURY N/A
- 52 Week Low
- OTLK $0.87
- FURY $0.32
- 52 Week High
- OTLK $12.85
- FURY $0.59
- Technical
- Relative Strength Index (RSI)
- OTLK 39.18
- FURY 47.29
- Support Level
- OTLK $1.79
- FURY $0.37
- Resistance Level
- OTLK $2.26
- FURY $0.42
- Average True Range (ATR)
- OTLK 0.18
- FURY 0.02
- MACD
- OTLK 0.00
- FURY 0.00
- Stochastic Oscillator
- OTLK 6.09
- FURY 25.17
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About FURY Fury Gold Mines Limited
Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.